Viewing nowCombinationExadipin Tablets 5/160 milligrams
Amlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Aprogen Bio, Co., Ltd.

MFDS item code 201403415 · Approved 2014.07.25 · Insurance code 645208360
Treatment of essential hypertension not controlled with monotherapy
This medicine is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy using amlodipine or valsartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or those undergoing dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; its use is not recommended.
This drug may cause serious harm to the fetus if taken during the second and third trimesters of pregnancy; therefore, women who are pregnant or may become pregnant should avoid taking it. This drug should not be taken if you have an allergy to the ingredients contained in this drug or similar class drugs. Patients with severely impaired kidney function or serious liver dysfunction should also avoid using this drug for safety. Diabetic patients with moderate to severe renal impairment should be cautious as taking this medication with certain other drugs may pose risks. If you have previously experienced facial or neck swelling due to angioedema or have taken related medications, you should not use this drug. Patients with severe aortic stenosis or in a state of shock are prohibited from using this drug. In conditions of sodium or fluid depletion in the body, this drug can cause hypotension, so you should check your status before taking it and supplement if necessary. Patients with high potassium levels may have increased potassium concentration when taking this drug, so frequent blood tests are required. Patients with renal artery stenosis need careful monitoring as there is a risk of worsening kidney function when taking this drug. There is insufficient safety data for patients who have recently undergone kidney transplantation, so use is not recommended. If symptoms of angioedema occur during the use of this drug, discontinue immediately and consult a physician. Patients with heart failure or after myocardial infarction should be closely monitored for changes in kidney function or hypotension when taking this drug. In acute myocardial infarction patients, some components of this drug may worsen angina or myocardial infarction symptoms, so caution is needed. Patients with aortic or mitral valve stenosis and those with obstructive hypertrophic cardiomyopathy require special attention when taking this drug. The risk of hypotension, worsening kidney function, and hyperkalemia may increase when this drug is used with other antihypertensive medications, so regular blood pressure monitoring and blood tests should be conducted as directed by a physician. Caution is needed as dizziness or fatigue may occur when driving or operating machinery. In case of overdose, symptoms such as hypotension, dizziness, and increased heart rate may occur; in such cases, you should visit a medical institution for appropriate treatment immediately. This drug is not recommended for children under 18 years of age, as safety and efficacy have not been sufficiently established. Elderly patients may be administered similar doses as adults, but they should be closely monitored. It is advisable to regularly check kidney function and electrolyte levels through blood tests during treatment with this drug. There may be interactions with other medications during this treatment, so you should consult a physician or pharmacist about all medications you are taking.
nasopharyngitis, influenza, hyper sensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, scrotal edema, facial swelling, peripheral edema, fatigue, flushing, myasthenia, facial flushing, decreased hemoglobin, decreased hematocrit, decreased neutrophils, decreased platelets, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disorder, peripheral neuropathy, muscle hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival overgrowth, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, discomfort in the chest, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroplasticity, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival dysplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This drug must be stored in a tightly sealed container to prevent exposure to air and moisture, and it is recommended to store it at room temperature between 1 degree and 30 degrees Celsius. Storing it this way will maintain the drug's effectiveness and prevent deterioration.
Yellow oval film-coated tablet
28 tablets (ALU-ALU X 2) / carton
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Aprogen Bio, Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.